Aug 28, 2026 06:40PM
Aug 28, 2026 06:40PM
Aug 5, 2026 06:10PM
Aug 5, 2026 06:10PM
Jul 30, 2026 02:37AM
Jun 15, 2026 12:00PM
Jun 9, 2026 04:30PM U.S. FDA Accepts Takeda's Application for Intravenous ENTYVIO® (vedolizumab) in Pediatric Ulcerative Colitis and Crohn's Disease
May 13, 2026 02:38AM
Mar 2, 2026 02:00AM
Feb 10, 2026 03:15AM
Jan 14, 2026 09:00AM
Jan 5, 2026 07:00AM
Dec 6, 2025 09:30AM
Nov 7, 2025 11:00AM Takeda Presents New Data Showing Mezagitamab (TAK-079) Sustained Effect on Kidney Function 18 Months After Treatment in Primary IgA Nephropathy
Oct 27, 2025 08:35AM
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM
Sep 8, 2025 03:00AM
Sep 8, 2025 03:00AM Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025
Sep 5, 2025 08:45PM
Sep 5, 2025 08:45PM
Jul 30, 2025 02:41AM
Jul 21, 2025 08:00AM
Jul 14, 2025 03:00AM
Jun 30, 2025 08:00AM
Jun 3, 2025 10:13AM Takeda (TAK) announces EC approval of ADCETRIS
Jun 3, 2025 10:12AM
Jun 1, 2025 08:00AM
May 14, 2025 05:03PM
May 5, 2025 08:00AM
Mar 3, 2025 06:45AM
Dec 3, 2024 07:00AM
Nov 7, 2024 07:00AM Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance
Sep 24, 2024 03:00AM
Sep 19, 2024 08:00AM
Aug 7, 2024 06:45AM
Aug 6, 2024 04:01PM
Jun 22, 2024 10:30PM
Jun 21, 2024 04:00PM
Jun 18, 2024 08:00AM Takeda Presents Long-Term Data from Phase 3 ADVANCE-CIDP 3 Clinical Trial of HYQVIA® in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) at PNS Annual Meeting
Jun 14, 2024 08:00AM
Jun 3, 2024 06:45AM
Jun 1, 2024 08:00AM
May 31, 2024 09:57AM
May 31, 2024 09:57AM
May 9, 2024 02:07AM
Apr 26, 2024 08:30AM HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
Apr 26, 2024 08:30AM

329,907 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All